Sinema Caves After Manchin Sells Out

[basquebromance]

 

[Oddball]

WTF?
Insulin has been around for 100 years.
A 10ml bottle cost about $450 in the US.
It cost $23 in Canada.

The first genetically engineered human insulin (also called biosynthetic human insulin, recombinant, or DNA-derived insulin) was manufactured by Eli Lilly Canada and authorized for the Canadian market in 1983. In 1993, biosynthetic human insulin made by Novo Nordisk entered the market. Prior to being authorized for sale in Canada, these products were thoroughly reviewed for their effectiveness, safety, and quality. Since then, human biosynthetic insulin has been shown to be safe and effective for treating type I and II diabetes.

How did their production cost NOT go up, but in the US...............It did?

No, they aren't moron.

there are only 2 or 3 companies making insulin (a quasi-monopoly) in Murica, shirtferbreains.....Why do you think that is, for a product that is so desperately needed?

 

[Nuthin' Fancy]

there are only 2 or 3 companies making insulin (a quasi-monopoly) in Murica, shirtferbreains.....Why do you think that is, for a product that is so desperately needed?

WTF, does THAT have to do with production cost, moron?

It has to do with greed.

Remember those guys who actually discovered insulin back in 1921? Dr. Frederick Banting and Charles Best were the main two, along with Dr. James Collip — all three had their names attached to the patent awarded in January 1923 to their method of making insulin.

When the researchers were ready to turn over the patent of their discovery to the University of Toronto for production purposes in 1923, they agreed to receive only $1 each (the equivalent of $14 today) in compensation.

Since insulin was in such high demand, the university granted Lilly (and other pharma companies) the right to make it, royalty-free, and also offered them the ability to improve the original formulation and patent anything they created down the road.

This Chicago Daily Tribune story from April 1, 1941, reports that a federal grand jury indicted a corporate trio — insulin manufacturer Eli Lilly in Indianapolis, distributor Sharp & Dohme in Philadelphia, and drug maker and distributor E.R. Squibb & Sons in New York — for conspiring to unlawfully “bring about arbitrary, uniform, and non-competitive prices for insulin and to prevent normal competition in the sale of the drug.” That was a federal charge of violating the Sherman Antitrust Act, the landmark legislation preventing anti-competitive business practices.

All three companies eventually pleaded “no contest,” but never admitted any wrongdoing. In July 1941, newspapers reported that the accused companies were fined $5,000 each and their corporate officers each faced $1,500 in individual fines for the price-fixing charges.